Medicare Enrolled

Dr. Rebekah Neal-Kraal, M.D.

Internal Medicine · Los Alamitos, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
10861 CHERRY ST, Los Alamitos, CA 90720
5627949801
In practice since 2009 (16 years)
NPI: 1215165667 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Neal-Kraal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Neal-Kraal? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Neal-Kraal

Dr. Rebekah Neal-Kraal is an internal medicine specialist in Los Alamitos, CA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Neal-Kraal performed 674 Medicare services across 375 unique beneficiaries.

Between the years covered by Open Payments, Dr. Neal-Kraal received a total of $39,967 from 51 pharmaceutical and/or device companies across 1311 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Neal-Kraal is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ Top 45% volume in CA $39,967 industry payments

Medicare Practice Summary

Medicare Utilization ↗
674
Medicare services
Top 45% in CA for internal medicine
375
Unique beneficiaries
$90
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~42 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
383 $99 $264
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
192 $60 $186
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
47 $131 $325
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
25 $82 $228
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
14 $150 $381
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
13 $41 $116
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$39,967
Total received (2018-2024)
Avg $5,710/year across 7 years
Top 4% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
1,311
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,732 (61.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$13,611 (34.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,625 (4.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,379
2023
$4,653
2022
$5,993
2021
$4,918
2020
$7,631
2019
$9,825
2018
$2,569

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$652
ABBVIE INC.
$587
Janssen Biotech, Inc.
$396
PFIZER INC.
$379
UCB, Inc.
$351
Novartis Pharmaceuticals Corporation
$265
Radius Health, Inc.
$246
Boehringer Ingelheim Pharmaceuticals, Inc.
$231
Organon Llc
$193
Fresenius Kabi USA, LLC
$187
Lilly USA, LLC
$170
ANI Pharmaceuticals, Inc.
$153
Aurinia Pharma U.S., Inc.
$137
AstraZeneca Pharmaceuticals LP
$115
GlaxoSmithKline, LLC.
$70
GENZYME CORPORATION
$65
Kiniksa Pharmaceuticals International, plc
$59
Alexion Pharmaceuticals, Inc.
$50
SOBI, INC
$35
Valinor Pharma, LLC
$21
IDORSIA PHARMACEUTICALS US INC
$16
Top 3 companies account for 37.3% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$10,181
Celgene Corporation
$6,083
UCB, Inc.
$2,461
Janssen Biotech, Inc.
$2,403
Novartis Pharmaceuticals Corporation
$2,065
ABBVIE INC.
$2,039
PFIZER INC.
$1,959
Lilly USA, LLC
$1,474
GlaxoSmithKline, LLC.
$1,184
AbbVie, Inc.
$1,166
AbbVie Inc.
$927
Horizon Therapeutics plc
$850
Radius Health, Inc.
$850
Boehringer Ingelheim Pharmaceuticals, Inc.
$841
Aurinia Pharma U.S., Inc.
$826
GENZYME CORPORATION
$651
AstraZeneca Pharmaceuticals LP
$629
Fresenius Kabi USA, LLC
$457
Alexion Pharmaceuticals, Inc.
$240
Mallinckrodt LLC
$220
ANI Pharmaceuticals, Inc.
$220
Organon Llc
$193
Daiichi Sankyo Inc.
$193
E.R. Squibb & Sons, L.L.C.
$193
Genentech USA, Inc.
$181
Mallinckrodt Enterprises LLC
$168
SANOFI-AVENTIS U.S. LLC
$124
Cumberland Pharmaceuticals, Inc.
$115
Flexion Therapeutics, Inc.
$103
Organon LLC
$97
Merck Sharp & Dohme Corporation
$81
Biocon Biologics Inc
$67
Antares Pharma, Inc.
$66
Collegium Pharmaceutical, Inc.
$62
RedHill Biopharma Inc.
$59
Kiniksa Pharmaceuticals International, plc
$59
Sandoz Inc.
$52
Ultragenyx Pharmaceutical Inc.
$49
Merck Sharp & Dohme LLC
$40
IDORSIA PHARMACEUTICALS US INC
$39
SOBI, INC
$35
Eisai Inc.
$35
Actelion Pharmaceuticals US, Inc.
$32
DePuy Synthes Sales Inc.
$31
Horizon Pharma plc
$30
Biohaven Pharmaceuticals, Inc.
$30
Alvogen Inc
$28
SUN PHARMACEUTICAL INDUSTRIES INC.
$22
Valinor Pharma, LLC
$21
MEDAC PHARMA, INC.
$21
Zyla Life Sciences
$14
Top 3 companies account for 46.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · Actemra · Aemcolo · Arcalyst · BELSOMRA · BENLYSTA · Bimzelx · COLOGUARD · COSENTYX · CYLTEZO · Cimzia · Crysvita · DUEXIS · Dayvigo · EVENITY · EVUSHELD · Enbrel · FLUMIST QUADRIVALENT · FORTEO · HADLIMA · HUMIRA · HYRIMOZ · Hulio · Humira · IDACIO · ILARIS · INFLECTRA · INJECTAFER · KAPSPARGO · KEVZARA · KINERET · KRYSTEXXA · LUPKYNIS · LYRICA · MOVANTIK · Morphabond ER · Movantik · NURTEC ODT · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · ORENCIA · ORTHOVISC · OTREXUP · Otezla · Otrexup · PEAK · PENNSAID · PURIFIED CORTROPHIN GEL · QUVIVIQ · RAYOS · REDITREX · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SHINGRIX · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · Strensiq · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · Tavneos · Tymlos · XELJANZ · XTAMPZA · ZORVOLEX · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (62%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for internal medicine in CA.

Looking for an internal medicine specialist in Los Alamitos?
Compare internal medicine physicians in the Los Alamitos area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
3,780
Per 100K population
119.5
County median income
$113,702
Nearest hospital
UCI HEALTH - LOS ALAMITOS
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Neal-Kraal is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 4% of CA peers, with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Neal-Kraal experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Neal-Kraal performed 383 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Neal-Kraal receive payments from pharmaceutical companies?
Yes. Dr. Neal-Kraal received a total of $39,967 from 51 companies across 1,311 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Neal-Kraal's costs compare to other internal medicine physicians in Los Alamitos?
Dr. Neal-Kraal's average Medicare payment per service is $90. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Neal-Kraal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →